Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.23.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current assets    
Cash, cash equivalents and restricted cash $ 89,001 $ 94,172
Short-term investments 272,533 295,218
Accounts receivable, net 19,046 13,483
Inventories, net 31,745 24,752
Prepaid expenses 10,096 13,580
Other current assets 1,227 1,334
Total current assets 423,648 442,539
Non-current assets    
Other non-current assets 13,357 13,339
Property and equipment, net 3,842 3,650
Acquired intellectual property and other intangible assets, net 6,101 6,425
Right-of-use assets, net 4,813 4,907
Total assets 451,761 470,860
Current liabilities    
Accounts payable and accrued liabilities 35,965 39,990
Deferred revenue 3,157 3,148
Other current liabilities 1,979 2,033
Operating lease liabilities 945 936
Total current liabilities 42,046 46,107
Non-current liabilities    
Deferred compensation and other non-current liabilities 12,321 12,166
Operating lease liabilities 6,986 7,152
Total liabilities 61,353 65,425
Commitments and contingencies (Note 17)
SHAREHOLDER’S EQUITY    
Common shares - no par value, unlimited shares authorized, 143,029 and 142,268 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively 1,193,019 1,185,309
Additional paid-in capital 88,885 85,489
Accumulated other comprehensive loss (988) (1,061)
Accumulated deficit (890,508) (864,302)
Total shareholders' equity 390,408 405,435
Total liabilities and shareholders’ equity $ 451,761 $ 470,860